Utay and Douek highlighted that the precise timing of type I IFN signaling in AHI is critical to determining clinical outcomes as insufficient IFN signaling during the first week of infection in an SIV infection model results in disease progression[46], and no study has boosted type I IFN signaling during acute HIV infection to examine whether this limits the reservoir. This evidence concerns the gene IFNA1 and HIV infectious disease.